Apollomics Inc

APLM
0,372
-0,0246 (-6,20%)
11 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
08/5/202422:05GLOBEApollomics Announces Private Placement Financing and..
25/4/202414:30GLOBEApollomics Announces Approval of Vebreltinib in China as a..
10/4/202413:00GLOBEApollomics Presents Vebreltinib Data at the 2024 American..
02/4/202414:00GLOBEApollomics Announces Poster Presentations of Vebreltinib..
28/3/202412:00GLOBEApollomics Highlights Clinical Progress and Reports Full..
26/3/202413:00GLOBEApollomics to Announce Full Year 2023 Financial Results and..
04/3/202413:00GLOBEApollomics Appoints Matthew Plunkett, Ph.D. as Chief..
07/2/202413:00GLOBEApollomics to Present at the Oppenheimer 34th Annual..
19/1/202422:15GLOBEApollomics Receives Nasdaq Notification Regarding Minimum..
17/1/202422:30GLOBEApollomics to Participate in a Fireside Chat at the B. Riley..
03/1/202413:00GLOBEApollomics Completes Enrollment in Phase 3 Bridging Study of..
02/1/202422:30GLOBEApollomics to Present at the 2024 Biotech Showcase
04/12/202313:00GLOBEApollomics Presents Interim Data from Two Ongoing Phase 2..
29/11/202313:30GLOBEApollomics to Participate in a Fireside Chat at the H.C...
28/11/202313:00GLOBEApollomics Announces Presentation of Vebreltinib Data at the..
16/11/202314:30GLOBEApollomics Announces the First Approval of Vebreltinib for..
31/10/202313:30GLOBEApollomics Announces Two New Cohorts in Global Phase 2..
26/10/202314:50GLOBEApollomics Announces Report of Activity of Vebreltinib in..
23/10/202314:30GLOBEApollomics Announces Efficacy of Vebreltinib in NSCLC..
17/10/202300:55GLOBEApollomics Announces Presentations of Vebreltinib Data at..
28/9/202322:17GLOBEApollomics Reports First Half 2023 Financial Results and..
06/9/202313:00GLOBEApollomics to Present at the H.C. Wainwright 25th Annual..
Apertura: 0,402 Min: 0,3611 Max: 0,418
Chiusura: 0,3966

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network